Document Detail


Octreotide efficacy in the treatment of chylothoraces following cardiac surgery in infants and children.
MedLine Citation:
PMID:  16575348     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To examine the efficacy of octreotide in resolving chylothoraces in infants and children following cardiac surgery. DESIGN: Retrospective chart review. SETTING: Pediatric intensive care unit of a tertiary care center. PATIENTS: All children who received octreotide for the treatment of chylothoraces following surgery for congenital heart disease over a 30-month period between 2001-2004. INTERVENTIONS: Octreotide infusion. MEASUREMENTS AND MAIN RESULTS: Eight courses of octreotide treatment were identified in seven patients who met our inclusion criteria. The median duration of therapy was 5 days, and dosing ranged from 1 to 4 microg/kg/hr. Treatment did not result in an overall decrease in average chest tube output after 3 days of therapy. However, in two patients (29%) the chylothoraces ultimately resolved during the octreotide infusion. Treatment was well tolerated, and no serious side effects were noted. CONCLUSION: In contrast to previously published reports, we find octreotide therapy for postoperative chylothoraces to be successful in only a minority of cases.
Authors:
Maple T Landvoigt; Charles J Mullett
Related Documents :
24446478 - Ministernotomy versus conventional sternotomy for aortic valve replacement: matched pro...
12464868 - Medial pancreatectomy: a multi-institutional retrospective study of 53 patients by the ...
23720248 - Prospective quality of life assessment between treatment groups for oral cavity squamou...
24830868 - Compressions during defibrillator charging shortens shock pause duration and improves c...
22739788 - Comparative effectiveness of preventative therapy for venous thromboembolism after coro...
16437598 - Relationship between body surface area and alt normalization after long-term lamivudine...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies     Volume:  7     ISSN:  1529-7535     ISO Abbreviation:  Pediatr Crit Care Med     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-05-09     Completed Date:  2006-11-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100954653     Medline TA:  Pediatr Crit Care Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  245-8     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, West Virginia University School of Medicine, Morgantown, WV, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chylothorax / drug therapy*,  etiology
Drug Administration Schedule
Female
Gastrointestinal Agents / administration & dosage,  therapeutic use*
Heart Defects, Congenital / surgery
Humans
Infant
Intensive Care Units
Male
Octreotide / administration & dosage,  therapeutic use*
Postoperative Complications / drug therapy*
Retrospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Gastrointestinal Agents; 83150-76-9/Octreotide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patien...
Next Document:  Serial circulating vasopressin levels in children with septic shock.